These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10097810)

  • 1. Acquired von Willebrand disease.
    van Genderen PJ; Michiels JJ
    Baillieres Clin Haematol; 1998 Jun; 11(2):319-30. PubMed ID: 10097810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.
    Mohri H
    J Thromb Thrombolysis; 2003 Jun; 15(3):141-9. PubMed ID: 14739623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
    Lison S; Dietrich W; Spannagl M
    Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand disease.
    Kumar S; Pruthi RK; Nichols WL
    Mayo Clin Proc; 2002 Feb; 77(2):181-7. PubMed ID: 11838652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia.
    Hegerova L; He F; Zantek ND; Vercellotti GM; Holtan SG; Reding MT
    Blood Cells Mol Dis; 2019 Jul; 77():109-112. PubMed ID: 31029024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulin.
    Michiels JJ; van Vliet HH
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):152-7. PubMed ID: 10726000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells.
    Richard C; Cuadrado MA; Prieto M; Batlle J; López Fernández MF; Rodriguez Salazar ML; Bello C; Recio M; Santoro T; Gomez Casares MT
    Am J Hematol; 1990 Oct; 35(2):114-7. PubMed ID: 2205095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome: features and management.
    Mohri H
    Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of acquired von Willebrand disease: a concise review.
    Shetty S; Kasatkar P; Ghosh K
    Eur J Haematol; 2011 Aug; 87(2):99-106. PubMed ID: 21535159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
    Frank RD; Kunz D; Wirtz DC
    Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment.
    Tefferi A; Nichols WL
    Am J Med; 1997 Dec; 103(6):536-40. PubMed ID: 9428838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.
    Dane KE; Lindsley JP; Kickler T; Streiff MB; Moliterno A; Yui J; Naik R; Chaturvedi S
    Blood Adv; 2021 Jul; 5(14):2813-2816. PubMed ID: 34269797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of acquired von Willebrand syndrome.
    Tiede A
    Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand's disease: a concise review.
    Rinder MR; Richard RE; Rinder HM
    Am J Hematol; 1997 Feb; 54(2):139-45. PubMed ID: 9034288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired von Willebrand's disease.
    Jakway JL
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1409-19. PubMed ID: 1452520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand disease in myeloproliferative disorders.
    van Genderen PJ; Leenknegt H; Michiels JJ; Budde U
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():79-82. PubMed ID: 8951776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand disease in children undergoing extracorporeal membrane oxygenation: a prospective observational study.
    Drop JG; Wildschut ED; de Maat MPM; van Rosmalen J; de Boode WP; de Hoog M; Heleen van Ommen C
    J Thromb Haemost; 2023 Dec; 21(12):3383-3392. PubMed ID: 37579879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.